Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 20.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 56,992 shares of the company’s stock after buying an additional 9,837 shares during the period. Atria Wealth Solutions Inc.’s holdings in Cardinal Health were worth $6,740,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in CAH. Raymond James & Associates increased its holdings in shares of Cardinal Health by 7.4% during the 3rd quarter. Raymond James & Associates now owns 309,960 shares of the company’s stock worth $34,257,000 after buying an additional 21,414 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Cardinal Health by 36.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 254,631 shares of the company’s stock worth $28,142,000 after buying an additional 68,382 shares during the last quarter. Sequoia Financial Advisors LLC increased its holdings in shares of Cardinal Health by 39.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 7,670 shares of the company’s stock worth $848,000 after buying an additional 2,178 shares during the last quarter. Signaturefd LLC increased its holdings in Cardinal Health by 18.7% in the 3rd quarter. Signaturefd LLC now owns 2,701 shares of the company’s stock valued at $298,000 after purchasing an additional 425 shares during the last quarter. Finally, Eastern Bank acquired a new stake in Cardinal Health in the 3rd quarter valued at approximately $25,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.3 %

Cardinal Health stock opened at $126.63 on Thursday. The stock has a market cap of $30.59 billion, a P/E ratio of 23.63, a price-to-earnings-growth ratio of 1.48 and a beta of 0.63. The company has a fifty day simple moving average of $123.25 and a 200-day simple moving average of $116.81. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Morgan Stanley lifted their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a report on Friday, January 31st. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $132.00 to $145.00 in a report on Monday, January 6th. Finally, Citigroup raised their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $136.87.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.